510(k) Report

510(k) · Cleared

Cleared

Ihealth BG5/BG5L Wireless Smart Glucose Monitoring System

K123935510(k) TraditionalCleared Apr 12, 2013113-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Andon Medical Co., Ltd. · NBW System, Test, Blood Glucose, Over The Counter

Cleared on Apr 12, 2013 as substantially equivalent to K120813 (Andon Medical Co., Ltd., 2012) and 1 other predicate after a 113-day review. Its family tree reaches back 5 generations to 2003. 3 later devices descend from it.

Decided
Apr 12, 2013
Review
113 days
Class
Class II
Product code
NBW
Recalls
None
Predicates
2

Its longest line of descent runs back 5 generations to K024194 (2003). 3 later devices descend from it, 1 citing it directly.

  1. Root · 5 generations backK024194 One Touch Ultra and One Touch Induo Blood Glucose Monitoring SystemsLifescan, Inc. · 2003 · Recalled
  2. 4 generations backK073030 AG-605 Blood Glucose Monitoring SystemAndon Health Co, Ltd. · 2008
  3. 3 generations backK093262 AG-608 Blood Glucose Monitoring System and AG-610 Blood Glucose…Andon Medical Co., Ltd. · 2010
  4. 2 generations backK110017 AG-608N Blood Glucose Monitoring SystemAndon Medical Co., Ltd. · 2012
  5. 1 generation backK120813 Blood Glucose Monitoring SystemAndon Medical Co., Ltd. · 2012
  6. This deviceK123935 Ihealth BG5/BG5L Wireless Smart Glucose Monitoring SystemAndon Medical Co., Ltd. · 2013
  7. Descendant · cites it directly · 2 of its ownK153278 Wireless Smart Gluco-Monitoring SystemAndon Health Co, Ltd. · 2016
  8. Descendant · 2 generations on · 1 of its ownK170231 iHealth Align Gluco-Monitoring System (BG1); iHealth Wireless Smart…Andon Health Co, Ltd. · 2017
  9. Descendant · 3 generations on · 0 of its ownK181070 iHealth Wireless Smart Gluco-Monitoring System (iHealth Gluco+)Andon Health Co, Ltd. · 2019

Most influential descendants

Showing 3 of 3 · See all
  • K153278Wireless Smart Gluco-Monitoring SystemAndon Health Co, Ltd. · 2016 · cites it directly2descendants
  • K170231iHealth Align Gluco-Monitoring System (BG1); iHealth Wireless Smart Gluco-Monitoring…Andon Health Co, Ltd. · 2017 · 2 generations on1descendant
  • K181070iHealth Wireless Smart Gluco-Monitoring System (iHealth Gluco+)Andon Health Co, Ltd. · 2019 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K024194One Touch Ultra and One Touch Induo Blood Glucose Monitoring SystemsLifescan, Inc.20035
−4K073030AG-605 Blood Glucose Monitoring SystemAndon Health Co, Ltd.2008—
−3K093262AG-608 Blood Glucose Monitoring System and AG-610 Blood Glucose Monitoring…Andon Medical Co., Ltd.2010—
−2K110017AG-608N Blood Glucose Monitoring SystemAndon Medical Co., Ltd.2012—
−1K120813Blood Glucose Monitoring SystemAndon Medical Co., Ltd.2012—
0 (this device)K123935Ihealth BG5/BG5L Wireless Smart Glucose Monitoring SystemAndon Medical Co., Ltd.2013—
+1K153278Wireless Smart Gluco-Monitoring SystemAndon Health Co, Ltd.2016—
+2K170231iHealth Align Gluco-Monitoring System (BG1); iHealth Wireless Smart…Andon Health Co, Ltd.2017—
+3K181070iHealth Wireless Smart Gluco-Monitoring System (iHealth Gluco+)Andon Health Co, Ltd.2019—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201610
201710
201910
FIG. 1 — Lineage of K123935, 2003–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NBW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBW device

  1. #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K120813Blood Glucose Monitoring System
Summary page 2
…Manufacturer: Andon Medical Co., Ltd. Device: Health BG3 Smart Gluco-monitoring System 510(k) number: k<120813 2 Manufacturer: Andon Medical Co., Ltd. Device: AG-608N Blood Glucose monitorin…
Andon Medical Co., Ltd.2012—
*K110017AG-608N Blood Glucose Monitoring System
Summary page 4
…ution iHealth Control solution AG-608N control solution (Level I/ 11/ Ill) (cleared in K110017) The control solution is exactly the same as…
Andon Medical Co., Ltd.2012—

Also cleared against K120813: 1 other device →

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K153278Wireless Smart Gluco-Monitoring SystemAndon Health Co, Ltd.20162

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 10 years and passes through 3 companies; a new generation was cleared every 1.5 years on median.
  • 1 of the 5 ancestors has a recall of any class.
  • Of its descendants, K153278 (Andon Health Co, Ltd., 2016) has gone furthest, with 2 descendants of its own.
  • 1 other device also cites its predicate K120813.

How does its category compare?

All NBW devices

NBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · NBW

2in 2025

2007: 292008: 372009: 382010: 312011: 302012: 302013: 472014: 242015: 322016: 202017: 252018: 192019: 102020: 72021: 72022: 122023: 52024: 72025: 22026 (partial year): 5
2007high 47 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBW

243in 2024

2007: 85 days median2008: 128 days median2009: 140 days median2010: 132 days median2011: 328 days median2012: 230 days median2013: 167 days median2014: 202 days median2015: 237 days median2016: 233 days median2017: 244 days median2018: 168 days median2019: 127 days median2020: 121 days median2021: 465 days median2022: 410 days median2023: 193 days median2024: 243 days median2026 (partial year): 190 days median
2007high 465 (2021) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBW

1in 2025

2007: 92008: 22009: 52010: 112011: 12012: 12013: 5, 2 Class I2014: 12016: 12019: 142025: 1
2007high 14 (2019) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · NBW

4,745in 2025

2007: 7,9912008: 7,7042009: 10,9632010: 11,6312011: 22,9092012: 23,4492013: 35,4082014: 38,5242015: 62,1112016: 76,6212017: 37,5382018: 16,9112019: 14,4722020: 10,7032021: 9,1982022: 8,1032023: 7,2562024: 6,2202025: 4,745
2007high 76,621 (2016) · low 4,745 (2025)2025

MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007298597,991
20083712827,704
200938140510,963
2010311321111,631
201130328122,909
201230230123,449
2013471675 (2)35,408
201424202138,524
201532237062,111
201620233176,621
201725244037,538
201819168016,911
2019101271414,472
20207121010,703
2021746509,198
20221241008,103
2023519307,256
2024724306,220
20252—14,745
202651900—

What is it indicated for?

Health BG5 wireless Smart Gluco-Monitoring System is intended to be used for: * quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertip, palm, forearm, upper arm, calf or thigh * single person measurement only and should not be shared * self-testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid to monitor the effectiveness of diabetes control Health 8G5 wireless Smart…

Read the full statement (441 words)

Health BG5 wireless Smart Gluco-Monitoring System is intended to be used for:

* quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertip, palm, forearm, upper arm, calf or thigh

* single person measurement only and should not be shared

* self-testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid to monitor the effectiveness of diabetes control

Health 8G5 wireless Smart Gluco-Monitoring System should not be used for the diagnosis of or screening for diabetes, or for neonatal use.

Alternative Site Testing (AST) should be done only during steady state times when glucose levels are not changing rapidly.

The AGS1 0001 test strips are intended for use with the iHealth 8G5 meter to quantitatively measure glucose in fresh capillary whole blood samples drawn from the fingertips, palm, forearm, upper arm, calf or thigh using the iHealth BG5 meter.

The iHealth control solutions are intended for use with the iHealth BG5 Blood Glucose Monitoring System, to check that the glucose meter and test strips are working properly. These solutions contain a known range of glucose, as indicated on the bottles.

The iHealth Gluco-Smart App is an iOS app for iPhone, iTouch, and iPad and is used for data extraction and analysis in iHealth BG5 and BG5L Wireless Smart Gluco-Monitoring System.

Health BG5L wireless Smart Gluco-Monitoring System is intended to be used for:

* quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertip, palm, forearm, upper arm, calf or thigh

* single person measurement only and should not be shared

* self-testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid to monitor the effectiveness of diabetes control

Health BG5L wireless Smart Gluco-Monitoring System should not be used for the diagnosis of or screening for diabetes, or for neonatal use.

Alternative Site Testing (AST) should be done only during steady state times when glucose levels are not changing rapidly.

The AGS 1000I test strips are intended for use with the iHealth BG5 meter to quantitatively measure glucose in fresh capillary whole blood samples drawn from the fingertips, palm, forearm, upper arm, calf or thigh using the iHealth BG5L meter.

The iHealth control solutions are intended for use with the iHealth BG5L Blood Glucose Monitoring System, to check that the glucose meter and test strips are working properly. These solutions contain a known range of glucose, as indicated on the bottles.

The iHealth Gluco-Smart App isan iOS app for iPhone, iTouch, and iPad and is used for data extraction and analysis in iHealth BG5 and BG5L Wireless Smart Gluco-Monitoring System.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K123935: Ihealth BG5/BG5L Wireless Smart Glucose Monitoring System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K123935

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026